| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 08/14/2003 | WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/14/2003 | WO2003021228A3 Heteroaryl substituted benzothiazole dioxetanes |
| 08/14/2003 | WO2003019145A3 Non-fluorescent quencher compounds and biomolecular assays |
| 08/14/2003 | US20030153784 Via direct hydrolysis of the chiral aminocarnitine ester in an acidic milieu to yield a chiral aminocarnitine inner salt without purifying the intermediate products; purity of >99%; resolution; enzyme inhibitor of carnitine palmoyl transferase |
| 08/14/2003 | US20030153783 Via direct hydrolysis of the chiral aminocarnitine ester in an acidic milieu to yield a chiral aminocarnitine inner salt without purifying the intermediate products; purity of >99%; resolution; enzyme inhibitor of carnitine palmoyl transferase |
| 08/14/2003 | US20030153762 Process for preparing imidazoquinolinamines |
| 08/14/2003 | US20030153752 Inhibitors of serine/threonine and tyrosine kinases |
| 08/14/2003 | US20030153691 Catalyst Supports comprising an addition polymer grafted with an aromatic diol, phosphorization, and metallization; use as hydroformylation and isomerization catalysts |
| 08/14/2003 | US20030153534 Phosphonate nucleotide compound |
| 08/14/2003 | US20030153533 Novel phospholipid derivatives |
| 08/14/2003 | US20030153532 Immunomodulatory compounds and methods of use thereof |
| 08/14/2003 | US20030152786 Polymerization of adduct of organosilicon compound |
| 08/14/2003 | US20030152551 2-Methyl-3-butenyl-1-pyrophosphoric acid salt and agent for treating lymphocytes |
| 08/14/2003 | US20030151019 Process for the preparation of organic solutions |
| 08/14/2003 | DE10223649C1 Preparation of triaryl and trialkyl phosphates, used e.g. as flame retardants, plasticizers, extractants or additives, uses technical grade phosphorus oxyhalide halogenated to pentahalide, then reacted with phenol or alkanol |
| 08/14/2003 | CA2474508A1 Ansamycins having improved pharmacological and biological properties |
| 08/14/2003 | CA2474142A1 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 08/13/2003 | EP1335416A1 Preparation of monoalkyl group 15 metal dihalides and dihydrides |
| 08/13/2003 | EP1334976A1 Novel phosphine compound, transition metal complex containing said compound as ligand and asymetric synthesis catalyst containing said complex |
| 08/13/2003 | EP1334139A2 Substituted pyridyl amine ligands, complexes and catalysts therefrom. processes for producing polyolefins therewith |
| 08/13/2003 | EP1334108A1 ARYL PHOSPHATE DERIVATIVES OF d4T |
| 08/13/2003 | EP1305445A4 Dark quenchers for donor-acceptor energy transfer |
| 08/13/2003 | EP1019411A4 Process for synthesizing carbapenem side chain intermediates |
| 08/13/2003 | EP0982986A4 Compositions for sustained release of a gas |
| 08/13/2003 | EP0927179B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 08/13/2003 | CN1436228A Oxoalcohol-based detergent |
| 08/13/2003 | CN1436167A Preparation of iminodiacetic acid compounds from monoethanolamine substrates |
| 08/13/2003 | CN1436077A Stabilized pharmaceutical compositions contg. calcium channel blockers |
| 08/13/2003 | CN1435420A Crystalline form of Adefovir dipivoxil and preparing process thereof |
| 08/13/2003 | CN1435419A Medical radioactive rhenium-aminophosphonic acid compound and preparing process thereof |
| 08/13/2003 | CN1435418A Aromatic nitrogen-contg. bis-phosphonic acid derivs., process for preparing same and use thereof |
| 08/13/2003 | CN1435417A Method for synthesis of 1-hydroxy-1,1-bis-phosphonic acids compounds |
| 08/13/2003 | CN1117728C Hydrocyanation of diolefins and isomerization of nonconjugated 2-alkyl-3-monoalkenenitriles |
| 08/13/2003 | CN1117723C Process for preparation of aldehyde |
| 08/13/2003 | CN1117629C Carbonylation catalyst system |
| 08/12/2003 | US6605745 Synthesis of P-chiral bisphospholane ligands and their transition metal complexes for use as asymmetric hydrogenation catalysts |
| 08/12/2003 | US6605742 Rheumatic diseases; antiarthritic agents; antitumor agents |
| 08/12/2003 | US6605740 Fluorescent dyes for the labeling of biological substrates |
| 08/12/2003 | US6605737 Process for the preparation of condensed phosphoric acid esters |
| 08/12/2003 | US6605736 Process for the preparation of condensed phosphoric esters |
| 08/12/2003 | US6605612 Cardioprotective phosohonates and malonates |
| 08/12/2003 | US6605568 Reacting particulate glyphosate acid and ammonia in water, exothermic, evaporation of the water to form a paste; herbicides |
| 08/12/2003 | US6605201 Charge transfer compounds comprising osmium compounds coupled to polymers, used as biosensors |
| 08/12/2003 | US6605200 Polymeric transition metal complexes and uses thereof |
| 08/07/2003 | WO2003064438A1 Amorphous monosodium alendronate and preparation thereof |
| 08/07/2003 | WO2003064406A1 Resistance-repellent retroviral protease inhibitors |
| 08/07/2003 | WO2003064393A1 Thio-carbostyril derivative, its n-oxides and the n-oxides of aripiprazole |
| 08/07/2003 | WO2003064383A2 Phosphorus-containing compounds & uses thereof |
| 08/07/2003 | WO2003064360A1 Synthetic tetraethers and synthesis strategies therefor |
| 08/07/2003 | WO2003064359A1 Bicyclic cb2 cannabinoid receptor ligands |
| 08/07/2003 | WO2003063758A2 Bicyclic cb2 cannabinoid receptor ligands |
| 08/07/2003 | WO2003011873A8 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| 08/07/2003 | US20030149290 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof |
| 08/07/2003 | US20030149267 Hydroformylating internal olefins with carbon monoxide and hydrogen in presence of diphosphine ligand to convert internal olefins to linear aldehydes with high selectivity |
| 08/07/2003 | US20030149119 For use as surfactants in emulsion polymerization reactions |
| 08/07/2003 | US20030149094 Compositions comprising ether compounds and pharmaceutical uses therefor |
| 08/07/2003 | US20030149023 Novel compounds with analgesic effect |
| 08/07/2003 | US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 08/07/2003 | US20030149003 Functionalized stilbene derivatives as improved vascular targeting agents |
| 08/07/2003 | US20030149001 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 08/07/2003 | US20030148877 Metallocenes and catalysts for olefin-polymerisation |
| 08/07/2003 | US20030148109 Novel mixture of polyhydroxy phenolic curing agents, such as novolac resins blended with a mixture of mono, bis and tris hydroxyaryl phosphine oxides for co-curing epoxy resins and imparting flame resistance. Printed circuits |
| 08/07/2003 | CA2474135A1 Bicyclic cb2 cannabinoid receptor ligands |
| 08/07/2003 | CA2473231A1 Resistance-repellent retroviral protease inhibitors |
| 08/06/2003 | EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 08/06/2003 | EP1017758B1 Thermostability enhancement of polyphosphate flame retardants |
| 08/06/2003 | EP0991317B1 Process and compositions promoting biological effectiveness of exogenous chemical substances in plants |
| 08/06/2003 | EP0983064B1 PYRROLES AS sPLA2 INHIBITORS |
| 08/06/2003 | CN1434828A Novel bisamidate phosphonate prodrugs |
| 08/06/2003 | CN1434812A Thizaolyl amide derivatives |
| 08/06/2003 | CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists |
| 08/06/2003 | CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 08/06/2003 | CN1434060A Borate photoinitiator obtained from polyborane |
| 08/06/2003 | CN1116871C Pharmaceutical compositions and containing S-alkylisothiouronium derivatives |
| 08/06/2003 | CN1116798C Microencapsulation formulation of codusafos |
| 08/05/2003 | US6603045 Preparing 3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-ylphosphonium salts as an intermediate for the preparation of lycopene by reacting the sale with 2,7-dimethylocta-2,4,6-trienedial |
| 08/05/2003 | US6603039 Carbon support having a noble metal at its surface, for use in catalyzing liquid phase oxidation reactions, especially in an acidic oxidative environment and in the presence of solvents, reactants, intermediates, or products which solubilize noble |
| 08/05/2003 | US6603032 1,2-bis(methyl(1,1,3,3-tetramethylbutyl)-phosphino)ethane, process the preparation thereof, transition metal complexes containing the same as a ligand and uses thereof |
| 08/05/2003 | US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 08/05/2003 | US6603030 Process for producing phosphineoxide vitamin D precursors |
| 08/05/2003 | US6602863 Irreversible inhibitors of tyrosine kinases |
| 08/05/2003 | US6602861 Acylated phospholipid drugs |
| 08/05/2003 | CA2089148C Oxidized complex comprising water-soluble carboxypolysaccaride and magnetic iron oxide |
| 07/31/2003 | WO2003062445A2 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis |
| 07/31/2003 | WO2003062253A1 Metal complexes for use in metathesis |
| 07/31/2003 | WO2003062252A1 Edg receptor agonists |
| 07/31/2003 | WO2003062251A1 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 07/31/2003 | WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/31/2003 | WO2003062247A2 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace) |
| 07/31/2003 | WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 07/31/2003 | WO2003062181A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 07/31/2003 | WO2003062180A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds |
| 07/31/2003 | WO2003062171A2 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 07/31/2003 | WO2003061826A1 Process for preparing nonracemic chiral alcohols |
| 07/31/2003 | WO2003061824A1 Process for preparing nonracemic chiral alcohols |
| 07/31/2003 | WO2003040159A8 Bidentate ligands for the carbonylation of unsaturated compounds |
| 07/31/2003 | WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses |
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | US20030144559 Catalyzing the reaction in presence of a transition metal compound and a ligand |
| 07/31/2003 | US20030144521 Hydrogenation of a corresponding nonracemic 1-(4-benzoxy phenyl)-2-(4-hydroxy-4- phenyl-piperidin-1-yl)-1-propanone using a catalyst system comprising ruthenium, a nonracemic diphosphine ligand, a bidentate amine ligand selected from |